Romiplostim Market, Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: RECE8976A567EN
Market Monitor Global

Abstracts

Romiplostim (rINN, USAN) is a fusion protein analog of thrombopoietin, a hormone that regulates platelet production.

This report contains market size and forecasts of Romiplostim in Global, including the following market information:

Global Romiplostim Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Romiplostim market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

250 ?g/0.5 mL Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Romiplostim include AMGEN. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Romiplostim companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Romiplostim Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Romiplostim Market Segment Percentages, by Type, 2021 (%)

• 250 ?g/0.5 mL
• 500 ?g/1 mL

Global Romiplostim Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Romiplostim Market Segment Percentages, by Application, 2021 (%)

• Adults
• Pediatric patients

Global Romiplostim Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Romiplostim Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Romiplostim revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Romiplostim revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AMGEN

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Romiplostim Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Romiplostim Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ROMIPLOSTIM OVERALL MARKET SIZE

2.1 Global Romiplostim Market Size: 2021 VS 2028
2.2 Global Romiplostim Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Romiplostim Players in Global Market
3.2 Top Global Romiplostim Companies Ranked by Revenue
3.3 Global Romiplostim Revenue by Companies
3.4 Top 3 and Top 5 Romiplostim Companies in Global Market, by Revenue in 2021
3.5 Global Companies Romiplostim Product Type
3.6 Tier 1, Tier 2 and Tier 3 Romiplostim Players in Global Market
  3.6.1 List of Global Tier 1 Romiplostim Companies
  3.6.2 List of Global Tier 2 and Tier 3 Romiplostim Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Romiplostim Market Size Markets, 2021 & 2028
  4.1.2 250 ?g/0.5 mL
  4.1.3 500 ?g/1 mL
4.2 By Type - Global Romiplostim Revenue & Forecasts
  4.2.1 By Type - Global Romiplostim Revenue, 2017-2022
  4.2.2 By Type - Global Romiplostim Revenue, 2023-2028
  4.2.3 By Type - Global Romiplostim Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Romiplostim Market Size, 2021 & 2028
  5.1.2 Adults
  5.1.3 Pediatric patients
5.2 By Application - Global Romiplostim Revenue & Forecasts
  5.2.1 By Application - Global Romiplostim Revenue, 2017-2022
  5.2.2 By Application - Global Romiplostim Revenue, 2023-2028
  5.2.3 By Application - Global Romiplostim Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Romiplostim Market Size, 2021 & 2028
6.2 By Region - Global Romiplostim Revenue & Forecasts
  6.2.1 By Region - Global Romiplostim Revenue, 2017-2022
  6.2.2 By Region - Global Romiplostim Revenue, 2023-2028
  6.2.3 By Region - Global Romiplostim Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Romiplostim Revenue, 2017-2028
  6.3.2 US Romiplostim Market Size, 2017-2028
  6.3.3 Canada Romiplostim Market Size, 2017-2028
  6.3.4 Mexico Romiplostim Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Romiplostim Revenue, 2017-2028
  6.4.2 Germany Romiplostim Market Size, 2017-2028
  6.4.3 France Romiplostim Market Size, 2017-2028
  6.4.4 U.K. Romiplostim Market Size, 2017-2028
  6.4.5 Italy Romiplostim Market Size, 2017-2028
  6.4.6 Russia Romiplostim Market Size, 2017-2028
  6.4.7 Nordic Countries Romiplostim Market Size, 2017-2028
  6.4.8 Benelux Romiplostim Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Romiplostim Revenue, 2017-2028
  6.5.2 China Romiplostim Market Size, 2017-2028
  6.5.3 Japan Romiplostim Market Size, 2017-2028
  6.5.4 South Korea Romiplostim Market Size, 2017-2028
  6.5.5 Southeast Asia Romiplostim Market Size, 2017-2028
  6.5.6 India Romiplostim Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Romiplostim Revenue, 2017-2028
  6.6.2 Brazil Romiplostim Market Size, 2017-2028
  6.6.3 Argentina Romiplostim Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Romiplostim Revenue, 2017-2028
  6.7.2 Turkey Romiplostim Market Size, 2017-2028
  6.7.3 Israel Romiplostim Market Size, 2017-2028
  6.7.4 Saudi Arabia Romiplostim Market Size, 2017-2028
  6.7.5 UAE Romiplostim Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AMGEN
  7.1.1 AMGEN Corporate Summary
  7.1.2 AMGEN Business Overview
  7.1.3 AMGEN Romiplostim Major Product Offerings
  7.1.4 AMGEN Romiplostim Revenue in Global Market (2017-2022)
  7.1.5 AMGEN Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Romiplostim Market Opportunities & Trends in Global Market
Table 2. Romiplostim Market Drivers in Global Market
Table 3. Romiplostim Market Restraints in Global Market
Table 4. Key Players of Romiplostim in Global Market
Table 5. Top Romiplostim Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Romiplostim Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Romiplostim Revenue Share by Companies, 2017-2022
Table 8. Global Companies Romiplostim Product Type
Table 9. List of Global Tier 1 Romiplostim Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Romiplostim Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Romiplostim Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Romiplostim Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Romiplostim Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Romiplostim Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Romiplostim Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Romiplostim Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Romiplostim Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Romiplostim Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Romiplostim Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Romiplostim Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Romiplostim Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Romiplostim Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Romiplostim Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Romiplostim Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Romiplostim Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Romiplostim Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Romiplostim Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Romiplostim Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Romiplostim Revenue, (US$, Mn), 2023-2028
Table 30. AMGEN Corporate Summary
Table 31. AMGEN Romiplostim Product Offerings
Table 32. AMGEN Romiplostim Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Romiplostim Segment by Type in 2021
Figure 2. Romiplostim Segment by Application in 2021
Figure 3. Global Romiplostim Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Romiplostim Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Romiplostim Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Romiplostim Revenue in 2021
Figure 8. By Type - Global Romiplostim Revenue Market Share, 2017-2028
Figure 9. By Application - Global Romiplostim Revenue Market Share, 2017-2028
Figure 10. By Region - Global Romiplostim Revenue Market Share, 2017-2028
Figure 11. By Country - North America Romiplostim Revenue Market Share, 2017-2028
Figure 12. US Romiplostim Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Romiplostim Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Romiplostim Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Romiplostim Revenue Market Share, 2017-2028
Figure 16. Germany Romiplostim Revenue, (US$, Mn), 2017-2028
Figure 17. France Romiplostim Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Romiplostim Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Romiplostim Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Romiplostim Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Romiplostim Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Romiplostim Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Romiplostim Revenue Market Share, 2017-2028
Figure 24. China Romiplostim Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Romiplostim Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Romiplostim Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Romiplostim Revenue, (US$, Mn), 2017-2028
Figure 28. India Romiplostim Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Romiplostim Revenue Market Share, 2017-2028
Figure 30. Brazil Romiplostim Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Romiplostim Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Romiplostim Revenue Market Share, 2017-2028
Figure 33. Turkey Romiplostim Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Romiplostim Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Romiplostim Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Romiplostim Revenue, (US$, Mn), 2017-2028
Figure 37. AMGEN Romiplostim Revenue Year Over Year Growth (US$, Mn) & (2017-2022)